AMD vs GEV: Which Is the Better Buy?

Side-by-side comparison of Advanced Micro Devices, Inc. and GE Vernova Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
Advanced Micro Devices, Inc. Β· Technology
$614.61
-13.7% upside to fair value
Med Conviction Grade C
VS
GE Vernova Inc. Β· Industrials
$951.82
+35.4% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
GEV has more upside to fair value (+35.4%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric AMD GEV
Current Price $614.61 $951.82
Fair Value Estimate $530.25 $1,288.67
Upside to Fair Value -13.7% +35.4%
Market Cap $1,002.2B $253.5B
Forward P/E β€” β€”
EV / EBITDA 93.4x 28.2x
Price / Sales 24.3x 6.1x
Price / FCF 119.3x 20.5x
Revenue Growth YoY +50.1% +21.9%
Gross Margin 53.2% 20.2%
Operating Margin 15.7% 4.4%
Return on Equity 10.1% 83.4%
Dividend Yield 0% 0.18%
FCF Yield 0.84% 4.88%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
AMD β€” Advanced Micro Devices, Inc.
Advanced Micro Devices designs x86 CPUs, GPUs, and data-center accelerators across two segments, Computing and Graphics and Enterprise, Embedded and Semi-Custom, with 31,000 employees and a $1.002 trillion market capitalization at $614.61 per share. The business quality is genuinely improving: revenue grew 50.1% year over year in the most recent quarter, earnings grew 163.4% year over year in the…
GEV β€” GE Vernova Inc.
GE Vernova is an energy equipment and infrastructure enterprise spanning Power (gas, nuclear, hydro, steam), Wind (offshore and onshore turbines), and Electrification (grid, power conversion, solar and storage), with 78,000 employees and a Cambridge, Massachusetts headquarters. The business quality is high on the strength of an installed base that generates roughly 25% of the world's electricity,…
Accumulation Zones
Metric AMD GEV
Zone Low $397.69 $966.50
Zone High $450.71 $1,095.37
In Buy Zone? No Yes
← AMD Research    GEV Research β†’    All Research